compared the therapeutic effect of nanopeptide KISS1R agonist MT-602 and kisspeptin 54 in PCOS women and found both MVT-602 and kp54 induced a LH peak with similar amplitude (171). This evidence concerns the gene KISS1 and polycystic ovary syndrome.